rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC.
Polcaro G, Liguori L, Manzo V, Chianese A, Donadio G, Caputo A, Scognamiglio G, Dell'Annunziata F, Langella M, Corbi G, Ottaiano A, Cascella M, Perri F, De Marco M, Col JD, Nassa G, Giurato G, Zeppa P, Filippelli A, Franci G, Piaz FD, Conti V, Pepe S, Sabbatino F.
Polcaro G, et al. Among authors: liguori l.
Mol Cancer. 2024 Mar 25;23(1):63. doi: 10.1186/s12943-024-01976-2.
Mol Cancer. 2024.
PMID: 38528526
Free PMC article.